COMPLEGENT Trademark

Trademark Overview


On Tuesday, April 5, 2022, a trademark application was filed for COMPLEGENT with the United States Patent and Trademark Office. The USPTO has given the COMPLEGENT trademark a serial number of 97347406. The federal status of this trademark filing is REGISTERED as of Tuesday, July 25, 2023. This trademark is owned by Kyowa Kirin Co., Ltd.. The COMPLEGENT trademark is filed in the Pharmaceutical Products category with the following description:

Host cells for medical or clinical use; cells for medical use, namely, cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; cells for medical use, namely, transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; Pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors being pharmaceutical products for treatment of blood pressure, agents for the treatment of asthma, antitussives and expectorants, stomachics and digestives for pharmaceutical purposes, antacids; hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis; corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia,...
complegent

General Information


Serial Number97347406
Word MarkCOMPLEGENT
Filing DateTuesday, April 5, 2022
Status700 - REGISTERED
Status DateTuesday, July 25, 2023
Registration Number7118859
Registration DateTuesday, July 25, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2023

Trademark Statements


Goods and ServicesHost cells for medical or clinical use; cells for medical use, namely, cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; cells for medical use, namely, transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; Pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors being pharmaceutical products for treatment of blood pressure, agents for the treatment of asthma, antitussives and expectorants, stomachics and digestives for pharmaceutical purposes, antacids; hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis; corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, Crohn's disease, and chronic active hepatitis; estrogen and progesterone preparations used as combined oral contraceptives; urinary antiseptics, analgesics, anti-itching agents; cataplasms for the treatment of bruises, lumbago and stiff shoulder; pharmaceutical preparations used to treat hair disorders; vitamin preparations; food enriching agents, namely, vitamin supplements, for treating vitamin deficiencies; anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa rolls and sticks for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs; germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and agricultural use; antiseptics, drugs for treating arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for pharmaceutical in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, drugs for treating Parkinson's disease; pharmaceuticals, namely, minor tranquilizers, and anti anxiety agents; pharmaceuticals, namely, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system; pharmaceuticals, namely, anti-bacterial preparations in the nature of antibacterial substances for medical purposes, monolithic preparations in the nature of substances for medical purposes, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations in the nature of radioactive substances, nutritive substances for microorganisms for medical purposes, pharmaceutical preparations for improving the metabolism and the peripheral circulation, blood plasma in the nature of plasma substitutes and extracorporeal circulation flow improvement preparations; diuretic and anti-hypertensive preparations; in vitro diagnostic reagents for medical use; in vitro extra corporeal diagnostic reagents for medical use; in vitro x-ray contrast agents for medical use; in vitro diagnostic media for medical use, and pharmaceutical preparations for the treatment of insomnia and other sleep related diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKyowa Kirin Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 100-0004
JP

Party NameKyowa Kirin Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 100-0004
JP

Party NameKyowa Kirin Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 100-0004
JP

Trademark Events


Event DateEvent Description
Tuesday, July 25, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 25, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 9, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2023PUBLISHED FOR OPPOSITION
Wednesday, April 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 5, 2023ELECTRONIC RECORD REVIEW COMPLETE
Friday, March 31, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Saturday, March 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 23, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 14, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 14, 2023NON-FINAL ACTION WRITTEN
Thursday, December 29, 2022ASSIGNED TO EXAMINER
Monday, April 25, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, April 21, 2022ASSIGNED TO LIE
Monday, April 18, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, April 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 8, 2022NEW APPLICATION ENTERED